UroGen Pharma Ltd. Lessee, Operating Lease, Liability, to be Paid, Year One
UroGen Pharma Ltd. (URGN) had Lessee, Operating Lease, Liability, to be Paid, Year One of $998.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $998.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $963.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $818.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $747.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One | Lessee, Operating Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2026-06-30 | $998.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $963.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $818.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | $747.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $364.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $58.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $822.00K 10-Q · filed 2025-05-12 | $824.00K 10-K · filed 2025-03-10 |
| 2024-09-30 | $820.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $817.00K 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $822.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $938.00K 10-K · filed 2024-03-14 | |
| 2023-09-30 | $923.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $923.00K 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $930.00K 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $1.15M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $1.16M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $875.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $358.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.14M 10-K · filed 2023-03-24 | |
| 2021-03-31 | $243.00K 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $1.31M 10-K · filed 2022-03-21 | |
| 2019-12-31 | $1.76M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |